Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (DESMOND) Lay Educator Study
ISRCTN ISRCTN99350009
ClinicalTrials.gov identifier
Public title Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (DESMOND) Lay Educator Study
Scientific title Testing a newly-developed training programme for lay educators delivering the Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (DESMOND) programme
Acronym N/A
Serial number at source 1
Study hypothesis The main aim of the study is to test the hypothesis that joint teams of lay educators and health care professionals can deliver structured education in diabetes with the same degree of interaction fidelity, quality and efficacy as health care professional teams. Equivalence of outcomes for patients who have attended sessions delivered by the two categories of team will be used as a proxy for equivalence in terms of delivery of effective education.
Ethics approval Leicestershire, Northamptonshire and Rutland Research Ethics Committee 1 approved on the 19th August 2009 (ref: 09/H0406/87)
Study design Open label parallel trial
Countries of recruitment United Kingdom
Disease/condition/study domain Diabetes
Participants - inclusion criteria 1. Over the age of 18 years, either sex
2. Newly diagnosed with type 2 diabetes
3. Can participate in the education programme preferably within 6 months of diagnosis
Participants - exclusion criteria 1. Type 1 diabetes
2. Taking insulin
3. Unable to give informed consent
4. Severe and enduring mental health problems (i.e. under the care of the specialist mental health team)
5. Unable to take part in a group programme
6. Not primarily responsible for their own care
7. Unable to participate in groups conducted in English (only for the non-BME sites)
Anticipated start date 08/01/2010
Anticipated end date 01/09/2010
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 256
Interventions GP/practice nurse will inform patients about the study and if interested hands them a study recruitment pack, which contains the Patient Information leaflet. The referral form is completed and sent to the local coordinator informing them patients interested. The co-ordinator contacts the patient by phone within a week, but not less than 24 hours after referral.

Patients who indicate their wish to join the study will be offered the first available study course. If the first course is judged unsuitable, they will be offered the next available study course. Once patients have been booked onto a study course they will be sent an appointment letter with a questionnaire booklet. When patients attend the course their consent will be taken by the health care professional educators before the start of the study course. The study courses will be delivered either as one full day or two half days.

This will be a one-off course that they will attend as part of the study and 4 months after attending the course patients will be sent a reminder letter, along with a questionnaire booklet, to have their data collected at their practice. GPs will be informed via a letter if their patients are taking part or not.
Primary outcome measure(s) Change in coherence score. This is an illness belief score which provides a measure of an individual’s understanding of their diabetes and is determined using a validated tool, the Diabetes Illness Perceptions Questionnaire (IPQ-R).
Secondary outcome measure(s) Based on changes between baseline and four months:
1. Change in personal responsibility score (obtained using the IPQ-R self-report questionnaire)
2. Change in depression score (obtained using the Hospital Anxiety and Depression Scale [HADS-D] self-report questionnaire)
3. Changes in biomedical and anthropometric measures
Sources of funding Diabetes UK (UK)
Trial website
Publications
Contact name Dr  Marian  Carey
  Address DESMOND Project Office
Ward 38
Level 6 Windsor Building
Leicester Royal Infirmary
Infirmary Square
  City/town Leicester
  Zip/Postcode Le1 5WW
  Country United Kingdom
  Email marian.carey@uhl-tr.nhs.uk
Sponsor University Hospitals of Leicester NHS Trust (UK)
  Address Gwendolen Road
  City/town Leicester
  Zip/Postcode LE5 4PW
  Country United Kingdom
  Email carolyn.maloney@uhl-tr.nhs.uk
  Sponsor website: http://www.uhl-tr.nhs.uk/
Date applied 22/12/2009
Last edited 01/02/2010
Date ISRCTN assigned 01/02/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central